Literature DB >> 9599333

Detection of JC virus DNA in cerebrospinal fluid from multiple sclerosis patients.

P Ferrante1, E Omodeo-Zorini, R Caldarelli-Stefano, M Mediati, E Fainardi, E Granieri, D Caputo.   

Abstract

JC virus (JCV), the causative agent of progressive multifocal leukoencephalopathy (PML), has been proposed as a possible aetiopathogenic factor in multiple sclerosis (MS). We performed a study to search the LT region of JCV genome by nested PCR in cerebrospinal fluid (CSF), peripheral blood mononuclear cell (PBMC) and urine samples collected from 121 MS patients, 24 patients with other neurological disorders (OND), 30 non neurological patients (NND) and in PBMCs and urine of 40 healthy subjects. JCV DNA has been found in the CSF of 11 MS patients (9%) while all the CSFs from the 24 OND and the 30 NND cases were negative. No significant differences have been observed as regard to the frequency of JCV DNA detection in PBMCs and urine between the MS patients and the control groups. Nucleotide sequences analysis of seven JCV CSF isolates showed that five strains were identical the prototypal strain, while the other two had a base mutation (T-->C) in 4286 nucleotide (nt). The finding of JCV DNA in the CSF of MS patients suggest that JCV could play a role in the triggering and/or in the maintenance of MS aetiopathogenic process, and therefore it should be taken in consideration when monitoring this disease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9599333     DOI: 10.1177/135245859800400202

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  19 in total

1.  JC viremia and multiple sclerosis.

Authors:  Daniele Focosi; Richard Eric Kast; Mario Petrini
Journal:  J Neurovirol       Date:  2008-01       Impact factor: 2.643

2.  Analysis of cerebrospinal fluid and cerebrospinal fluid cells from patients with multiple sclerosis for detection of JC virus DNA.

Authors:  E Iacobaeus; C Ryschkewitsch; M Gravell; M Khademi; E Wallstrom; T Olsson; L Brundin; Eo Major
Journal:  Mult Scler       Date:  2008-09-19       Impact factor: 6.312

3.  Reply to letter to the editor: "JC viremia and multiple sclerosis" by Focosi et al.

Authors:  Serena Delbue; Franca Rosa Guerini; Roberta Mancuso; Domenico Caputo; Romina Mazziotti; Marina Saresella; Pasquale Ferrante
Journal:  J Neurovirol       Date:  2008-01       Impact factor: 2.643

Review 4.  Diagnosis and Treatment of Progressive Multifocal Leukoencephalopathy Associated with Multiple Sclerosis Therapies.

Authors:  Eric M L Williamson; Joseph R Berger
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620

Review 5.  The evolving face of human immunodeficiency virus-related progressive multifocal leukoencephalopathy: defining a consensus terminology.

Authors:  Paola Cinque; Igor J Koralnik; David B Clifford
Journal:  J Neurovirol       Date:  2003       Impact factor: 2.643

6.  Progressive multifocal leukoencephalopathy associated with isolated CD8+ T-lymphocyte deficiency mimicking tumefactive MS.

Authors:  Jennifer L McGuire; Vera Fridman; Christian Wüthrich; Igor J Koralnik; Dina Jacobs
Journal:  J Neurovirol       Date:  2011-07-23       Impact factor: 2.643

Review 7.  The role of polyomaviruses in human disease.

Authors:  Mengxi Jiang; Johanna R Abend; Silas F Johnson; Michael J Imperiale
Journal:  Virology       Date:  2008-11-07       Impact factor: 3.616

8.  JC virus viremia in interferon-beta -treated and untreated Italian multiple sclerosis patients and healthy controls.

Authors:  Serena Delbue; Franca Rosa Guerini; Roberta Mancuso; Domenico Caputo; Romina Mazziotti; Marina Saresella; Pasquale Ferrante
Journal:  J Neurovirol       Date:  2007       Impact factor: 2.643

9.  Macrophage IL-12p70 signaling prevents HSV-1-induced CNS autoimmunity triggered by autoaggressive CD4+ Tregs.

Authors:  Kevin R Mott; David Gate; Mandana Zandian; Sariah J Allen; Naveen Kumar Rajasagi; Nico van Rooijen; Shuang Chen; Moshe Arditi; Barry T Rouse; Richard A Flavell; Terrence Town; Homayon Ghiasi
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-04-08       Impact factor: 4.799

Review 10.  Induction of tolerance in autoimmune diseases by hematopoietic stem cell transplantation: getting closer to a cure?

Authors:  Richard K Burt; Shimon Slavin; William H Burns; Alberto M Marmont
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.319

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.